Wellington Management Group’s Entrada Therapeutics TRDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.13M | Buy |
1,060,716
+7,402
| +0.7% | +$49.7K | ﹤0.01% | 1297 |
|
|
2025
Q1 | $9.52M | Buy |
1,053,314
+21,488
| +2% | +$194K | ﹤0.01% | 1211 |
|
|
2024
Q4 | $17.8M | Buy |
1,031,826
+2,457
| +0.2% | +$42.5K | ﹤0.01% | 1008 |
|
|
2024
Q3 | $16.4M | Sell |
1,029,369
-4,558
| -0.4% | -$72.8K | ﹤0.01% | 1015 |
|
|
2024
Q2 | $14.7M | Buy |
1,033,927
+7,087
| +0.7% | +$101K | ﹤0.01% | 1034 |
|
|
2024
Q1 | $14.6M | Sell |
1,026,840
-20,940
| -2% | -$297K | ﹤0.01% | 1021 |
|
|
2023
Q4 | $15.8M | Buy |
1,047,780
+2,128
| +0.2% | +$32.1K | ﹤0.01% | 1000 |
|
|
2023
Q3 | $16.5M | Buy |
1,045,652
+26,144
| +3% | +$413K | ﹤0.01% | 975 |
|
|
2023
Q2 | $15.4M | Buy |
1,019,508
+5,055
| +0.5% | +$76.5K | ﹤0.01% | 1005 |
|
|
2023
Q1 | $14.7M | Buy |
1,014,453
+4,102
| +0.4% | +$59.5K | ﹤0.01% | 1008 |
|
|
2022
Q4 | $13.7M | Buy |
1,010,351
+3,105
| +0.3% | +$42K | ﹤0.01% | 1003 |
|
|
2022
Q3 | $15.9M | Sell |
1,007,246
-528,637
| -34% | -$8.33M | ﹤0.01% | 980 |
|
|
2022
Q2 | $18.7M | Sell |
1,535,883
-1,007,219
| -40% | -$12.3M | ﹤0.01% | 959 |
|
|
2022
Q1 | $23.8M | Sell |
2,543,102
-570,904
| -18% | -$5.35M | ﹤0.01% | 977 |
|
|
2021
Q4 | $52.8M | Buy |
+3,114,006
| New | +$52.8M | 0.01% | 799 |
|